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Reversible posttranslational modifications are
emerging as critical regulators of mitochondrial pro-
teins and metabolism. Here, we use a label-free
quantitative proteomic approach to characterize
the lysine succinylome in liver mitochondria and its
regulation by the desuccinylase SIRT5. A total of
1,190 unique sites were identified as succinylated,
and 386 sites across 140 proteins representing
several metabolic pathways including b-oxidation
and ketogenesis were significantly hypersucciny-
lated in Sirt5/ animals. Loss of SIRT5 leads to
accumulation of medium- and long-chain acylcarni-
tines and decreased b-hydroxybutyrate production
in vivo. In addition, we demonstrate that SIRT5 regu-
lates succinylation of the rate-limiting ketogenic
enzyme 3-hydroxy-3-methylglutaryl-CoA synthase 2
(HMGCS2) both in vivo and in vitro. Finally, mutation
of hypersuccinylated residues K83 and K310 on
HMGCS2 to glutamic acid strongly inhibits enzy-
matic activity. Taken together, these findings
establish SIRT5 as a global regulator of lysine succi-
nylation in mitochondria and present a mechanism
for inhibition of ketogenesis through HMGCS2.
INTRODUCTION
Proteins undergo posttranslational modifications that modulate
their structural conformation, activity, stability, or subcellular
localization. Small acyl groups, such as acetyl, modify lysine
side chains, resulting in lysine acetylation and neutralization of
its positive charge. Succinylation was recently identified as
another significant modification of lysine residues (Zhang et al.,920 Cell Metabolism 18, 920–933, December 3, 2013 ª2013 Elsevier2011). The substrate for succinylation is presumably the succinyl
group derived from succinyl-CoA. Since the succinyl group is
more bulky and causes a greater change in charge than an acetyl
group, one could expect that succinylation will affect protein
function in ways that are different from acetylation. Acetyl-CoA
and succinyl-CoA are important metabolites at central nodes
of intermediary metabolism, including oxidative and anaplerotic
fluxes through the tricarboxylic acid (TCA) cycle. During cata-
bolic conditions, acyl-CoAs of different lengths can be generated
from the breakdown of diverse nutrient substrates, and their
levels may fluctuate substantially under different metabolic
conditions (He et al., 2012; Newman et al., 2012). The different
acyl-CoAs and their modification of proteins might therefore
constitute an important signaling mechanism for cells to sense
and respond to changes in metabolic status (He et al., 2012;
Newman et al., 2012).
Accumulating evidence suggests that protein acetylation
dynamically interacts with proteins involved in energy meta-
bolism. In prokaryotes and eukaryotes, acetylation regulates
the functions of many metabolic enzymes (Wang et al., 2010;
Zhao et al., 2010). Lysine acetylation is regulated by the
competing activities of acetyltransferases, such as p300, and
deacetylases, such as the nicotinamide adenine dinucleotide
(NAD+)-dependent class III protein deacetylase sirtuins (Glozak
et al., 2005). Three of the 7 mammalian sirtuins, SIRT3, SIRT4,
and SIRT5, are located in mitochondria. SIRT3 is the major
deacetylase in mitochondria (Lombard et al., 2007). Our recent
label-free quantitative proteomic study of the lysine acetylome
reveals that SIRT3 targets about 13% of all acetylated lysines
identified on 136 proteins in mitochondria, many of which are
critical metabolic enzymes (Rardin et al., 2013). Mitochondrial
protein hyperacetylation due to SIRT3 deficiency has severe
consequences and may lead to metabolic disorders in mice
and humans (He et al., 2012; Hirschey et al., 2011).
The regulation of lysine succinylation is less well understood.
SIRT5, a mitochondrial sirtuin with very weak deacetylase activ-
ity, is a potent desuccinylase (Du et al., 2011; Peng et al., 2011).Inc.
Figure 1. Generation of Succinyl-Lysine-Specific Antibodies and Characterization of Succinylation Distribution in Mouse Tissues, Cultured
Cells, and Subcellular Compartments
(A) The structure of lysine succinylation and the catalytic reaction of desuccinylation by SIRT5. The succinyl group on the lysine residue is indicated in red.
(B) Succinyl-lysine antibodies specifically detected succinyl-BSA, but not acetyl-BSA or butyryl- or propionyl-BSA.
(C) Western blot using succinyl-lysine-specific antibodies was performed to assess succinylation and acetylation levels in mouse liver, skeletal muscle, primary
cultured mouse hepatocytes, andMEFs derived from wild-type (WT) or Sirt5/mice (see also Figure S1A). Equal amounts of protein were loaded into each lane.
Loading controls, a-tubulin and mitochondrial protein HSP70, were also examined. Western blot for SIRT5 confirmed the absence of SIRT5 protein in Sirt5/
mouse tissues or cells.
(D) Protein succinylation and acetylation in whole-cell lysates and cytoplasmic or mitochondrial fractions derived fromWT or Sirt5/mouse livers. Western blot
for cytoplasmic protein a-tubulin and mitochondrial protein voltage-dependent anion channel (VDAC) confirmed the purity of subcellular fractionation. Western
blot for SIRT5 showed the presence of SIRT5 in both cytoplasm and mitochondria of WT livers, but not in Sirt5/ livers.
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SIRT5 Regulates the Mitochondrial SuccinylomeThe catalytic reaction involves the removal of a succinyl group
from the lysine side chain of protein substrates, consumes
NAD+ as a cosubstrate, and generates nicotinamide (NAM) and
20-O-succinyl-ADP-ribose (Figure 1A). Two amino acids—tyro-
sine (Y102) and arginine (R105), located within the catalytic
pocket of SIRT5—are required for desuccinylase activity (Du
et al., 2011). Their positive charges may explain the preference
of SIRT5 for negatively charged acyl groups, such as succinyl-
lysine. Studies that address the biological role of lysine succiny-
lation and its regulation by SIRT5 have been hampered by a lack
of knowledge of the proteins and lysine residues that contain
succinyl modifications. Only two studies have characterized
SIRT5 function. These reported a role for SIRT5 in regulating
the urea cycle enzyme carbamoyl phosphate synthetase 1
(CPS1) by desuccinylation (Du et al., 2011) or possibly deacety-
lation (Nakagawa et al., 2009). Therefore, characterization of the
lysine succinylome across the entire mitochondrial proteome will
shed light on the biological function of succinylation and SIRT5.
In the present study, we generated antibodies for the specific
enrichment of succinyl-lysine-containing peptides and applied a
label-free quantitative proteomic method called MS1 filtering
(Schilling et al., 2012) to characterize the mitochondrial succiny-
lome in a metabolically active and highly aerobic organ, liver of
wild-type (WT) and Sirt5/mice. Pathway analysis of SIRT5 tar-
geted proteins followed by both in vitro and in vivo investigationCell Mfurther revealed an important role for SIRT5 in regulating fatty
acid b-oxidation and ketone body synthesis.
RESULTS
Lysine Succinylation Is Strongly Enriched in Liver
Mitochondria
To detect pan-lysine succinylation, we generated polyclonal
antibodies by immunizing a rabbit with succinylated keyhole
limpet hemocyanin. The specificity of newly developed anti-
bodies was tested by western blot analysis with BSA carrying
several distinct acylation modifications. Two rabbit sera con-
taining succinyl-lysine antibodies, H1006 and H1007, showed
strong and specific reaction with succinyl-BSA, but not with
acetyl-BSA, butyryl-BSA, or propionyl-BSA (Figure 1B). In
contrast, the acetyl-lysine antibody strongly recognized acetyl-
BSA and the pan-butyryl- and propionyl-lysine antibody recog-
nized butyryl-BSA and propionyl-BSA (Figure 1B).
Next, we screened global protein succinylation in various
organs and primary cell lines of WT or Sirt5/ mice with these
antibodies. In agreement with published data showing a potent
desuccinylase activity of SIRT5 (Du et al., 2011; Peng et al.,
2011), protein succinylation increased in Sirt5/mouse tissues,
including liver, skeletal muscle, and primary hepatocytes (Fig-
ures 1C and S1A). In contrast, protein acetylation levels wereetabolism 18, 920–933, December 3, 2013 ª2013 Elsevier Inc. 921
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SIRT5 Regulates the Mitochondrial Succinylomeunchanged in both Sirt5/mouse tissues and primary cell lines
(Figures 1C and S1A). Importantly, levels of succinyl-CoA and
succinate remain unchanged in the Sirt5/ animals under
both the fed and fasted state, implicating SIRT5 as the major
regulator of lysine succinylation (Figures S1B and S1C). Surpris-
ingly, lysine succinylation was least abundant in mouse embry-
onic fibroblasts (MEFs) when compared with equal amounts of
protein (Figure 1C). As SIRT5 is localized to both the cytoplasmic
and mitochondrial compartments, we examined the amount of
total protein succinylation in these two subcellular fractions.
Mouse liver mitochondria were strongly enriched in lysine succi-
nylated proteins while a mitochondrial depleted cytoplasmic
fraction showedminimal staining when equal amounts of protein
were compared (Figure 1D). These results confirm the broad de-
succinylase activity of SIRT5 across tissues in vivo and indicate
succinylated proteins are strongly enriched in liver mitochondria.
Defining and Quantifying the Lysine Succinylome in
Liver Mitochondria
To identify proteins and specific sites of lysine succinylation in
mitochondria, we developed a workflow to enrich succinylated
peptides for identificationbymassspectrometry (MS) (Figure2A).
Mouse liver mitochondria were isolated from five WT and five
Sirt5/ mice by differential centrifugation. Equal amounts of in-
dividual protein samples were digested with trypsin, and 15 mg
was removed to quantify protein expression levels in WT and
knockout (KO) mice. A heavily labeled succinylated lysine (SuK)
peptide, ADIAESQVNsuKLR[13C6
15N4], was spiked into the re-
maining mitochondrial protein digest as a process-loading
control and normalization factor for subsequent label-free quan-
tification. As we showed that multiple antibodies increase the
diversity of enrichment (Schilling et al., 2012), succinylated
peptides were immunoprecipitated with equal amounts of two
polyclonal antibodies (Figure 1B). Samples were analyzed in
duplicate by liquid chromatography (LC)-MS/MS on a TripleTOF
5600 MS, and data were searched against the mouse proteome.
We identified 2,183 SuK peptides with a false discovery rate
(FDR) of% 1% (Table S1) that correspond to 1,190 lysine succi-
nylation sites across 252 proteins (Figure 2B). Of the 1190 sites
identified, 64% were identified only in the KO, 10% only in the
WT, and 26% in both (Figure S2). When the data were searched
against other lysine modifications, such as acetylation andmalo-
nylation, no additional sites were identified, demonstrating the
specificity of the antibodies for lysine succinylation.
Within themouse liver succinylome, we sought to identify sub-
strates of SIRT5 with a label-free quantitative method, MS1
filtering (Schilling et al., 2012). With this method, we canmeasure
intact precursor ion abundance for succinylated peptides across
WT and KO samples. The peptide standard had a coefficient of
variation (CV) of 24%across all samples, indicating strong repro-
ducibility between enrichments. We used published criteria to
select representative peptides for quantitation, including charge
state abundance, tryptic cleavage, and lack of secondary mod-
ifications (Rardin et al., 2013). Precursor ion intensities were
normalized to the peptide standard before calculating peptide
ratios (KO:WT). Quantitative data generated on 992 sites
from 221 proteins revealed 32% of SuK sites (386) across 56%
of the identified proteins (140) were increased by more than
2-fold (p < 0.01) (Figure 2B and Table S2). Sites of increased suc-922 Cell Metabolism 18, 920–933, December 3, 2013 ª2013 Elseviercinylation in the KO samples showed a wide distribution of
changes, with 386 sites increased by more than 2-fold and 92
sites increased by more than 10-fold (Figure 2C). To control for
possible changes in protein expression levels in response to
the loss of SIRT5, we used MS1 filtering to quantitatively analyze
peptides from the total mitochondrial protein digest before
enrichment. Samples from each mouse were analyzed in dupli-
cate by LC-MS/MS, and peptides quantified from 203 of the
252 succinylated proteins identified in our SuK enrichment
showed no changes in expression and average peptide KO:WT
ratios near 1.0. These results indicate the observed changes in
SuK peptide abundances were due to change in protein succiny-
lation in the absence of SIRT5 and not to altered protein expres-
sion levels (Table S3). Peptides quantified from an additional 33
nonsuccinylated mitochondrial proteins were also unchanged in
the KO mice (Table S3), suggesting limited remodeling of the
mitochondrial proteome in response to SIRT5 deletion.
Loss of SIRT5 Leads to Hypersuccinylation of
Mitochondrial Proteins
MS1 filtering analysis revealed large-scale increases in lysine
succinylation at specific sites from a variety ofmitochondrial pro-
teins (Figure 2D). We identified 12 SuK sites on the electron
transport chain (ETC) complex V subunit, ATPO, that showed
the most robust increase in succinylation at K97 with a > 300-
fold increase. Several other sites on this protein were unchanged
(Table S2). Other proteins showed strong increases in SuK,
including the urea cycle enzyme carbamoyl phosphate synthe-
tase 1 at K1486, the TCA cycle enzyme malate dehydrogenase
at K239, and several enzymes involved in fatty acid metabolism,
including 3-ketoacyl-CoA thiolase, acyl-coenzyme A synthetase
medium-chain family member 1, enoyl-CoA delta isomerase 1,
and the trifunctional enzyme a subunit. Therefore, loss of
SIRT5 leads to a dramatic increase in site-specific SuK of mito-
chondrial proteins across several metabolic pathways.
We calculated the enrichment of SIRT5 target SuK on proteins
by using a binomial distribution analysis. Fifteen proteins are
significantly more abundant with SIRT5 target sites than ex-
pected from the total number of SuK sites on each protein (Fig-
ure 2E, p < 0.05). For instance, SIRT5 targets 18 out of 22 SuK
sites on the trifunctional enzyme a subunit, 12 out of 15 sites
on 3-hydroxy-3-methylglutaryl-CoA synthase 2, and 9 out of 10
sites on citrate synthase (Figure 2E and Table S2). Importantly,
multiple enzymes involved in fatty acid metabolism and ketone
body metabolism show up on the lists of highly regulated sites
(Figure 2D) and highly regulated proteins (Figure 2E), which are
highlighted in blue on both figures.
Succinylation does not appear to be evenly distributed across
themitochondrial proteome. More than 80 proteins have a single
SuK site, and 12 proteins have at least 15 SuK sites (Figure 3A).
Almost half of succinylated proteins contain a single SIRT5 target
site, while four proteins have more than 10 SIRT5 target sites
(Figure 3B).
Succinylation and SIRT5 Target Sites with Distinct
Sequence Motif Features
As succinylation and SIRT5 appear to selectively target specific
sites, we were intrigued to determine if there is a common se-
quencemotif for succinylation orSIRT5 regulation.WecomparedInc.
Figure 2. Enrichment and Identification of Liver Mitochondrial Lysine Succinylome by Label-free Quantitation
(A) Liver mitochondria were isolated from five individual WT and Sirt5/mice. Mitochondrial protein from each of the ten samples was digested separately with
trypsin and desalted, and then 150 fmol of a heavy isotope-labeled succinyl-lysine peptide standard was added. Succinyl-lysine-containing peptides were
immunoprecipitated and analyzed in duplicate by LC-MS/MS. Precursor ion intensity chromatograms were integrated using MS1 filtering in Skyline for label-free
quantitation. Venn diagrams of lysine succinylated proteins and peptides identified in WT and Sirt5/ are shown in Figure S2.
(B) Overlap of the number of succinylated peptides and proteins identified with the number that were targeted by SIRT5 (>2-fold increase and p < 0.01). For
peptide information and quantitation of individual sites, see Tables S1 and S2.
(C) Scatterplot of the SuK peptides quantitated byMS1 filtering. Dashed lines indicate the fold change of abundance in KO samples in comparison toWT samples.
Peptides with a significant change are shown in blue (p < 0.05), and the others are in red. Inset summarizes the number of SuK peptides that show significant
change in KO samples.
(D) Largest fold changes (KO:WT) for individual SuK sites with the average protein expression ratio displayed.
(E) Highly regulated proteins enriched with SIRT5 target sites with the average protein expression ratio displayed. Number of SIRT5 target sites in black, number
of nontarget sites in gray. See Tables S3 and S4 for mass spectrometry details of identified peptides used for protein quantification.
ATP synthase subunit O, ATPO; carbamoyl-phosphate synthetase 1, CPSM; 3-ketoacyl-CoA thiolase, THIM; acyl-coenzyme A synthetase medium-chain family
member 1, ACSM1; malate dehydrogenase, MDHM; enoyl-CoA delta isomerase, ECI1; acetyl-CoA acetyltransferase, THIL; glutamate dehydrogenase, DHE3;
trifunctional enzyme a subunit, ECHA; ADP/ATP translocase 2, ADT2; 3-hydroxy-3-methylglutaryl-CoA synthase 2, HMCS2; citrate synthase, CISY; 3-hy-
droxyisobutyryl-CoA hydrolase, HIBCH; aconitase, ACON; acyl-CoA synthetase family member 2, ACSF2; enoyl-CoA delta isomerase 2, ECI2; GDP-specific
succinyl-CoA synthetase b subunit, SUCB2; HSP10, CH10; 3-hydroxybutyrate dehydrogenase, BDH; ADP-specific succinyl-CoA synthetase b subunit, SUCB1;
3-hydroxy-3-methylglutaryl-CoA lyase, HMGCL; prostaglandin G/H synthase 2, PHS2; and succinyl-CoA synthetase a subunit, SUCA.
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Figure 3. Site Distribution, Conservation, and Sequence Logo Analysis
(A) Distribution of the number of succinylation sites per protein.
(B) Distribution of the number of SIRT5 target sites per protein. For peptide information and quantitation of individual sites, see Tables S1 and S2.
(C and D) Consensus sequence logo plot for succinylation sites ± ten amino acids from the lysine of all succinylated sites identified (C) and from the lysine of all
SIRT5 target sites (D) (>2-fold and p < 0.01). SIRT5 target sequence context heatmap is also shown in Figure S3A.
(E) Heatmap depicting the conservation index of the SIRT5 target sites across seven vertebrate species. Percent conservation calculated for all succinylated
sites, SIRT5 target sites or nontarget sites is shown above the heatmap. Lysine (K), glutamine (Q), arginine (R), aspartic acid (D), or glutamic acid (E) and other
amino acids are presented in different colors. Heatmap depicting the conservation index of nontarget sites is available at Figure S3B. See Table S5 for con-
servation index analysis details.
(F) Venn diagrams showing the overlap of succinylated and acetylated lysine residues identified in mouse liver mitochondria and the overlap of sites that are
targeted by SIRT5 and SIRT3.
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SIRT5 Regulates the Mitochondrial Succinylomethe amino acid sequences surrounding all succinylated sites to
nonsuccinylated sites (Figure 3C) or all SIRT5 target sites to
nontarget succinylated sites (Figure 3D) by IceLogo (https://
code.google.com/p/icelogo/). Notably, positively charged amino
acids (lysine or arginine) were strongly excluded from positions
1 and +1 of the succinylation logo (Figure 3C). Positions close
to the modified site (2, 1, and +2) had modest enrichment
for small nonpolar hydrophobic amino acids, such as leucine,
valine, or isoleucine, while positions farther away (10 to 7
and +4 to +10) were enriched with positively charged lysine or
arginine (Figure 3C). The SIRT5 target logo is distinct from the
succinylation logo. Notably, serine or threonine was enriched at
multiple positions (8, 6, 5, 4, 1, +1 and +3) of the SIRT5
target logo (Figure 3D). The average KO/WT fold change of all
SuK peptides with a given amino acid at a given position was
calculated and illustrated in a sequence context heatmap (Fig-
ure S3A). Interestingly, serine and threonine were preferred at
positions 6, 4, 1, +1, +3 and +5, which coincide with the
SIRT5 target sequence logo generated using IceLogo.
Conservation Analysis of Succinylation and SIRT5
Target Lysine Sites
Lysine succinylation is found from yeast to mammal (Zhang
et al., 2011). Sirtuins are a highly conserved family of proteins
(Greiss and Gartner, 2009). We therefore determined if succiny-
lated sites or SIRT5 target sites are evolutionarily conserved by
generating a conservation index across vertebrate proteomes
with AL2CO (Pei and Grishin, 2001). Of the SuK sites identified
in mouse liver mitochondria, 86% were conserved in human
(Homo sapiens) and 67% were conserved in zebrafish (Danio
rerio) (Figure 3E). The conservation of SuK sites or SIRT5 target
sites in any of the other six species (human, rat, cattle, bird, frog,
zebrafish) across vertebrates was above 60%, when compared
against mouse. About 29% of SIRT5 target sites were 100%
conserved in all seven species. The conservation index was,
however, not apparently different between SIRT5 target sites
and nontarget sites, except in zebrafish (p < 0.001, chi-square
test) (Figures 3E and S3B).
Lysine Acetylome and Succinylome Overlap
Significantly in the Mitochondria
To determine the extent of the overlap of lysine modifications in
liver mitochondria with succinylation, we compared our succiny-
lation data to our recently published data set of SIRT3-targeted
mitochondrial lysine acetylation in mouse liver that employed
similar enrichment and label-free quantification methods (Rardin
et al., 2013). Of 1,190 sites of lysine succinylation across 252
proteins identified in the present study, we find that 939 sites
(79%) were also acetylated in the SIRT3 study (Figure 3F).
This indicates a strong overlap of succinylation and acetylation
on lysine residues inmitochondrial proteins. However, of all iden-
tified sites, only 93 were targeted by both SIRT5 and SIRT3 when
we used a 2-fold increase cutoff (p < 0.01) in their respective
knockout models (Figure 3F).
Pathway Analysis Reveals Fatty Acid b-Oxidation and
Ketone Body Production as Highly Targeted by SIRT5
To gain more insight into how succinylation and SIRT5 regu-
late mitochondrial metabolic networks, we performed pathwayCell Menrichment analysis with Reactome (http://www.reactome.org).
Many metabolic pathways are significantly enriched with succi-
nylation target proteins (Figure 4A) or SIRT5 target proteins (Fig-
ure 4B). The top pathways enriched with SIRT5 targets are
b-oxidation, branched-chain amino acid catabolism, TCA cycle,
ATP synthesis, ketone body synthesis, and propionyl-CoA
catabolism, which are all critical nodes in energy metabolic net-
works. Strikingly, 100%of proteins (4 out of 4) in ketogenesis and
93% of proteins (14 out of 15) in b-oxidation are targeted by
SIRT5, as compared to 58% (11 out of 19) in branched-chain
amino acid catabolism, 43% (10 out of 23) in TCA cycle, or
43% (9 out of 21) in ATP synthesis.
b-oxidation is the process of fatty acid catabolism into acetyl-
CoA in themitochondria. Four core steps are carried out sequen-
tially by acyl-CoA dehydrogenase family proteins (ACAD)
(dehydrogenation) and the trifunctional enzyme (hydration /
oxidation/ thiolysis) (Figure 4C). During each cycling, a two-
carbon acetyl group is liberated and activated to form acetyl-
CoA. The remaining acyl-CoA shortened by two carbons
continues cycling through the four steps until complete oxida-
tion. Three ACAD family proteins of various chain length prefer-
ences, including very long chain, long chain, and medium chain,
and the trifunctional enzyme a and b subunits are all targeted by
SIRT5, with some proteins targeted at multiple sites (Figures 4C
and 4D). SIRT5 targeted sites are exceptionally abundant on the
trifunctional enzyme a subunit which is also a target of SIRT3
(Rardin et al., 2013). The two catalytic domains enoyl-CoA hydra-
tase and 3-hydroxyacyl-CoA dehydrogenase responsible for
two sequential steps of b-oxidation, hydration and oxidation,
are heavily targeted by SIRT5.
Acetyl-CoA produced during b-oxidation can enter the
ketone body synthesis pathway in the liver to generate ketone
bodies such as acetoacetate and b-hydroxybutyrate for energy
use in extrahepatic tissues such as the heart and brain when
carbohydrates become limiting (Figure 4C). All four enzymes
in ketone body synthesis pathway are targeted by SIRT5 at
multiple sites (Figures 4C and 4D). Notably, 3-hydroxy-3-
methylglutaryl-CoA synthase 2 (HMGCS2), which controls the
rate-limiting conversion of acetoacetyl-CoA and acetyl-CoA
into 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA), contains the
most succinyl-lysine sites and the most SIRT5 target sites (Fig-
ures 4C and 4D).
Decreased Fatty Acid Oxidation and Increased
Accumulation of Acylcarnitines in the Absence of SIRT5
The striking enrichment of SIRT5 desuccinylation targets in the
fatty acid b-oxidation pathway prompted us to determine if
hypersuccinylation due to loss of SIRT5 alters fatty acid meta-
bolism. Oxidation of deuterium-labeled palmitate was measured
in primary cultures of hepatocytes isolated from WT or Sirt5/
mice. After incubating the cells with deuterium-labeled palmi-
tate-BSA conjugates, deuterium in C-2H bonds was released
from palmitate and incorporated into water. The rate of palmitate
oxidation was calculated from the production of deuterium-
labeled water in the culture medium. Oxidation of palmitate
increased over time in both WT and Sirt5/ cells (Figure 5A).
However, Sirt5/ cells oxidized significantly less palmitate at
both time points. When cells were cultured in glucose-deprived
medium for 24 hr, oxidation of palmitate significantly increasedetabolism 18, 920–933, December 3, 2013 ª2013 Elsevier Inc. 925
Figure 4. Fatty Acid b-Oxidation and Ketone Body Synthesis Are Highly Targeted by SIRT5
(A and B) Pathway analysis of succinylation (A) and SIRT5 targets (B) with the number of proteins identified per pathway. Fatty acid b-oxidation and ketone body
synthesis are highlighted in blue.
(C) Schematic depicting the core machinery of fatty acid b-oxidation and ketone body synthesis with SIRT5 target sites indicated on each protein.
(D) Succinylation profiles of enzymes involved in fatty acid b-oxidation and ketone body synthesis. KO:WT ratio of each SuK site is shown in scatterplots. Red
horizontal bar represents the median KO:WT ratio of all SuK sites on each protein. Dotted line indicates a KO:WT ratio of 2.
Very-long-chain acyl-CoA dehydrogenase, ACADV; long-chain acyl-CoA dehydrogenase, ACADL; medium-chain acyl-CoA dehydrogenase, ACADM; short-
chain acyl-CoA dehydrogenase, ACADS; trifunctional enzyme a subunit, ECHA; trifunctional enzyme b subunit, ECHB; 2,4-dienoyl-CoA reductase, DECR; enoyl-
CoA delta isomerase 1, ECI1; short-chain enoyl-CoA hydratase, ECHM; short-chain 3-hydroxyacyl-CoA dehydrogenase, HCDH; acetoacetyl-CoA thiolase, THIL;
3-hydroxy-3-methylglutaryl coenzyme A synthase 2, HMCS2; 3-hydroxy-3-methylglutarate-CoA lyase, HMGCL; and 3-hydroxybutyrate dehydrogenase, BDH.
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Figure 5. Lack of SIRT5 Is Associated with Impaired Fatty Acid b-Oxidation and Accumulation of Acylcarnitines
(A) Oxidation of deuterium-labeled palmitate in primary cultured hepatocytes isolated from WT (black bars) or Sirt5/ (blue bars) mice measured after a 24 or
48 hr incubation. y axis represents mmoles of deuterium-labeled palmitate oxidized per 106 cells (n = 3). Results are shown as the mean ± SD.
(B) Oxidation of deuterium-labeled palmitate, when cultured in control medium or glucose-deprived medium or treated with 100 mM Etomoxir (ETO), measured
after 24 hr incubation (n = 3). Results are shown as the mean ± SD.
(C) Oxidation of tritium-labeled palmitate inMEFs derived fromWT (black bars) orSirt5/ (blue bars) mice after a 3 or 24 hr incubation. y axis represents nmoles of
tritium-labeled palmitate oxidized per milligram of proteins (3 hr, n = 8; 24 hr, n = 7). Results are shown as the mean ± SD.
(D) Concentrations of acylcarnitines in liver or skeletal muscle of Sirt5/ mice are shown as relative values compared to WT. The gray rectangles and their
corresponding vertical gray lines show the chain-length-level inference (posterior mean and 95% CI). The horizontal lines and shapes show stratum-specific
inference. Table below shows estimated percent increase, 95% CI, and p value calculated for relative acylcarnitine concentrations in KO versus WT in liver,
skeletal muscle, or combined. Relative concentrations of individual acylcarnitines in KO versus WT are also shown in Figure S4.
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even under glucose-deprived conditions. Etomoxir, an irrevers-
ible carnitine palmitoyltransferase 1 inhibitor, blocks long-chain
fatty acid transport into the mitochondria and therefore inhibits
fatty acid b-oxidation. Etomoxir coincubation drastically attenu-
ated palmitate oxidation in both WT and Sirt5/ cells, support-Cell Ming the sensitivity and specificity of this assay (Figure 5B). These
data suggest a potential deficiency of b-oxidation in Sirt5/
hepatocytes.
To further confirm these results, we used MEFs derived
from WT or Sirt5/ mice and applied another tracer approach
with tritium labeling. In agreement with the findings in primaryetabolism 18, 920–933, December 3, 2013 ª2013 Elsevier Inc. 927
(legend on next page)
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significantly reduced in Sirt5/ MEFs after a 3 or 24 hr incuba-
tion (Figure 5C).
Next, to explore the role of lysine succinylation in fatty acid
metabolism in vivo, we examined the levels of acylcarnitines,
which are intermediates, of b-oxidation in WT and Sirt5/
mouse tissues. In both liver and skeletal muscle tissues from
KO animals, there was a broad accumulation of medium- and
long-chain acylcarnitines including saturated acylcarnitine spe-
cies, poly- and monounsaturated acylcarnitines, hydroxyacyl-
carnitines, and dicarboxylates (Figure 5D), consistent with the
global protein hypersuccinylation observed in these tissues
from Sirt5/ mice (Figures 1C and S1A). Statistical analysis
of both liver and skeletal muscle acylcarnitines in a combined
model demonstrated a significant increase in medium- and
long-chain acylcarnitines in KO tissues (p < 0.001 for long-
chain; p = 0.02 for medium-chain) when compared to WT
tissues, while no significant difference was observed in short-
chain acylcarnitines (Figure 5D). Taken together, this abnormal
accumulation of b-oxidation intermediates supports in vitro
flux assays and is consistent with a deficient oxidation of
endogenous fatty acids in the absence of SIRT5 in both liver
and skeletal muscle.
Lack of SIRT5 Is Associated with Decreased Ketone
Body Production and Hypersuccinylation of HMGCS2
Given that all four key enzymes in ketone body synthesis are
highly succinylated and targeted by SIRT5, we further tested
whether ketone body production was altered in the absence
of SIRT5 by measuring plasma b-hydroxybutyrate levels in
WT or Sirt5/ mice. No difference was observed between
WT and Sirt5/ mice under basal condition (Figure 6A). How-
ever, under fasting condition, Sirt5/ mice showed signifi-
cantly decreased b-hydroxybutyrate production at all time
points measured starting from 4 hr until 24 hr fasting (Figure 6A).
b-hydroxybutyrylcarnitine levels can reflect the pool of b-hy-
droxybutyrate in cells, as it is a mitochondrial intermediate
derived from b-hydroxybutyryl-CoA. Levels of b-hydroxybutyr-
ylcarnitine in Sirt5/ mouse liver were significantly lower than
in WT mouse liver under 24 hr fasted condition (Figure 6B),
which further supports a deficient ketone body production in
Sirt5/ mice.
To investigate how succinylation and SIRT5 may regulate
ketone body production, we focused on HMGCS2, the rate-
limiting step of ketone body synthesis. HMGCS2 is hypersucci-Figure 6. Lack of SIRT5 Leads to Decreased b-Hydroxybutyrate Produ
(A) Plasma b-hydroxybutyrate levels in WT and Sirt5/ mice at 0, 4, 12, 16, and
mean ± SEM.
(B) Liver b-hydroxybutyrylcarnitine levels in WT and Sirt5/ mice under fed or 2
(C) Western blot showing succinylation of endogenous HMGCS2 immunoprecip
calculated and are shown relative to WT mice.
(D) Expression plasmids for WT HMGCS2 were transfected into HEK293 cells w
mutant). Immunoprecipitation andwestern blot were performed to examine succin
are shown relative to empty vector control.
(E) HEK293 cells overexpressing WT HMGCS2 were infected with lentivirus carry
SIRT5. Immunoprecipitation and western blot were performed to examine succiny
are shown relative to scrambled shRNA treatment.
(F) Mass spectrum peak intensity of all identified succinyl-lysine-containing pepti
each site (KO:WT) is indicated above the bars.
Cell Mnylated at 12 of 15 succinyl lysine residues in the absence of
SIRT5 (Figures 4C and 4D). To examine SIRT5 regulation of
HMGCS2 succinylation in vivo, we immunoprecipitated endoge-
nous HMGCS2 from WT or Sirt5/ mouse livers and examined
its succinylation by western blot (Figure 6C). Quantification of
three independent experiments confirmed that succinylation of
HMGCS2 is significantly higher in Sirt5/mice when compared
to WT mice (Figure 6C). In contrast, overexpression of SIRT5
reduced succinylation of HMGCS2 in HEK293 cells (Figure 6D).
Surprisingly, overexpression of a catalytically inactive mutant,
SIRT5-H158Y, led to hypersuccinylation of HMGCS2, sug-
gesting it may act as a dominant-negative protein. Finally,
knockdown of SIRT5 via shRNA led to hypersuccinylation of
overexpressed HMGCS2 in HEK293 cells (Figure 6E).
Succinylation of Lysine Residues within the Substrate
Binding Pocket Inhibits HMGCS2 Activity
Among the 15 succinylated lysine residues identified on
HMGCS2, several sites appear to be highly targeted by SIRT5,
including K83, K310, K350, K354, and K358 (Figure 6F). To
further investigate the possible effects of succinylation at these
residues, we examined the crystal structure of human HMGCS2
bound to HMG-CoA (Figure 7A) (Shafqat et al., 2010). The struc-
ture reveals a cluster of lysine residues targeted by SIRT5 adja-
cent to the substrate-binding pocket of HMGCS2 with lysine
amine nitrogens for residues 83, 306, and 310 within 4 A˚ of the
phosphate oxygen atoms of the substrate acetyl-CoA (Fig-
ure 7B). The observed peak intensity of specific succinyl-lysine
residue-containing peptides is plotted with respect to their dis-
tance to the nearest CoA phosphate group (Figure 7C). Strik-
ingly, lysine residues K83 and K310, which are among the
closest to the CoA phosphate group, are also most intensely
succinylated. This observation suggests the negative charge of
added succinyl groups would likely disrupt these lysines’ inter-
actions with the phosphate groups of acetyl-CoA if not removed
by SIRT5.
To test the possible effects of succinylation at these sites on
HMGCS2 activity, we generated FLAG-tagged constructs of
WT HMGCS2 or mutants to mimic the negative charge state of
the succinyl group including K83E, K310E, and the double
mutant (K83/310E). Individual constructs were transfected into
HEK293 cells and proteins were isolated by immunoprecipitation
(Figure S5). Steady-state kinetic analysis was carried out using
acetyl-CoA and acetoacetyl-CoA as substrates, and activity
was measured by release of CoA-SH at increasingction and Hypersuccinylation of HMGCS2
24 hr following fasting (n = 5, **p < 0.001, *p < 0.01). Results are shown as the
4 hr fasted condition (n = 5). Results are shown as the mean ± SEM.
itated from WT or Sirt5/ mouse liver (n = 3). Integrated density values were
ith an empty vector control, SIRT5 WT, or SIRT5 H158Y (catalytically inactive
ylation levels of HMGCS2 (n = 3). Integrated density valueswere calculated and
ing scrambled shRNA or two different shRNAs for specifically knocking down
lation levels of HMGCS2 (n = 5). Integrated density values were calculated and
des measured in WT (black bars) and Sirt5/mice (blue bars). Fold change of
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Figure 7. HMGCS2 Mutations at Sites of
Succinylation within the Substrate Binding
Region Regulate Its Enzymatic Activity
(A) Ribbon diagram of the crystal structure of
human HMGCS2 (PDB entry 2WYA) bound with
HMG-CoA. Lysines fully observed in the crystal
structure are shown in yellow, and lysines without
fully defined conformations in the crystal structure
are modeled in PyMol using low-energy all-trans
rotamers as allowed by local backbone and
steric interactions and displayed as green atomic
spheres at 50% scale.
(B) The interactions between several lysine side
chains and the negatively charged CoA phosphate
groups in the substrate binding pocket are shown
in detail. Lysine amine nitrogens for residues 83,
306, and 310 are within 4 A˚ of the phosphate
oxygen atoms.
(C) The observed mass spectrum peak intensity of
succinyl-lysine-containing peptides plotted with
respect to their distance to the nearest CoA
phosphate. Dotted lines connect the same pep-
tide identified in WT and Sirt5/ mice.
(D) Steady-state kinetic analysis of WT HMGCS2
and succinyl-lysine mimetics HMGCS2-K83E,
HMGCS2-K310E, and HMGCS2-K83,310E enzy-
matic activity as measured by DTNB detection of
CoA-SH released from increasing concentrations
of acetyl-CoA at 412 nM. Graph is representative
of two independent experiments, n = 3 measure-
ments/sample, mean ± SD. Inset contains values
for average Km and Vmax ± SEM. The purity and
equal amounts of immunoprecipitated HMGCS2
WT or mutants are shown in Figure S5.
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WT HMGCS2 kinetic activity were reasonably similar to previous
reports (Andrew Skaff and Miziorko, 2010; Shimazu et al., 2010),
the individual mutants (K83E, K310E) and the double mutant
(K83/310E) exhibited a complete loss of enzymatic activity (Fig-
ure 7D). Given the robust changes in succinylation at K83 and
K310 in Sirt5/ mice, their close proximity to the substrate
binding pocket, and the loss of function when replaced with a
negatively charged amino acid, our data support the model930 Cell Metabolism 18, 920–933, December 3, 2013 ª2013 Elsevier Inc.that lysine succinylation and desuccinyla-
tion by SIRT5 can regulate HMGCS2 ac-
tivity through disrupting and restoring
the binding pocket for phosphate groups
of acetyl-CoA, respectively.
DISCUSSION
The reversible succinylation of lysines is a
recently identified posttranslational
modification with largely unknown preva-
lence or biological function. The present
study identified 1,190 unique succinyl-
lysine sites on 252 proteins in mouse liver
mitochondria in a robust affinity-enrich-
ment and rigorous label-free quan-
tification approach. Furthermore, SIRT5deficiency in the liver leads to the selective hypersuccinylation
(at least 2-fold) at 386 sites on 140 proteins, indicating that
32% of identified SuK sites are SIRT5 target sites and about
56% of succinylated proteins are SIRT5 target proteins. Proteins
in major metabolic pathways are targeted by succinylation and
SIRT5. These pathways include ketogenesis, fatty acid b-oxida-
tion, TCA cycle, and ATP synthesis, which are crucial compo-
nents of a cell’s energy metabolic networks. In addition, we
show that hypersuccinylation occurs on almost all proteins
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of SIRT5 and that this switch in the succinylation state is associ-
atedwith accumulation of bothmedium- and long-chain acylcar-
nitines as well as decreased ketone body production during
fasting. Finally, we propose a mechanism by which lysine succi-
nylation can negatively regulate ketogenesis through modifica-
tion of the substrate binding pocket of HMGCS2.
After completion of our study, data emerged on lysine succiny-
lation in liver tissue and SIRT5 targeted succinylation in MEFs
from WT and Sirt5/ animals (Park et al., 2013). Interestingly
of the 1,200 sites Park et al. identified in MEFs, only 294
were also identified in liver tissue, suggesting a dramatic rear-
rangement of the succinylome when moving into a cell culture-
based system. As sirtuins are thought to play a major role in
metabolism, this may be reflective of the transition from in vivo
to in vitro conditions. We observed a similar dramatic decrease
in global protein succinylation when comparing mouse tissues
with MEFs by western blot (Figure 1C). Of the 997 quantifiable
sites in MEFs, only 18% overlapped with our liver mitochondrial
analysis, indicating that Park et al. were able to generate a
broader cellular overview of lysine succinylation while our
approach gained much deeper coverage of SIRT5-targeted
mitochondrial proteins.
The biological function of SIRT5 remains largely obscure.
Global Sirt5/mice develop normally and appear normal under
basal, unchallenged conditions (Lombard et al., 2007). The regu-
lation of CPS1 by SIRT5 has a role in ammonia detoxification and
disposal during conditions when protein catabolism increases,
such as fasting, long-term calorie restriction, or a high-protein
diet resulting in abnormally elevated ammonia level (Nakagawa
et al., 2009). The present study has demonstrated a role for
SIRT5 in regulating ketogenesis through hypersuccinylation of
HMGCS2. Interestingly, succinyl-CoA was previously proposed
to inhibit HMGCS2 by autosuccinylation of the active site
cysteine residue (Lowe and Tubbs, 1985). Follow-up studies
suggested that increased levels of succinyl-CoA in vitro could
affect HMGCS2 activity presumably through succinylation
(Quant et al., 1989). However, succinyl-CoA levels in our studies
appeared unchanged in both fed and fasted states, indicating
that increased succinylation was due to loss of SIRT5 and not
to an overall increase in succinyl-CoA levels. Based on the
crystal structure, our data indicate that lysines adjacent to the
substrate binding site of HMGCS2 are intensely succinylated
(Figure 7C), which suggests that succinyl-CoA may interact
with lysine residues around the catalytic pocket, leading to
nonenzymatic modifications of these lysines. Importantly, a
negative charge at residues K83 and K310 strongly inhibits
HMGCS2 activity, probably through disrupting the binding
pocket for phosphate groups of the substrate acetyl-CoA. While
other robustly succinylated residues on HMGCS2 (K256, K350,
and K354) near the binding pocket would not directly interact
with the bound CoA group in the crystal structure, these sites
may contribute to initial steps of acetyl-CoA binding through
electrostatic interactions.
Succinylation is an abundant lysine modification in mitochon-
dria. The 252 identified succinylated proteins have 1,190 SuK
sites and a total of 6,579 lysines. Since our affinity-enrichment
approach was unlikely to cover all possible succinylated pep-
tides, we can conclude that at least 18% of lysines on these pro-Cell Mteins are modified by succinylation. Succinylation, however, is
not evenly distributed among all proteins, as some have more
succinylated sites than others despite containing a similar num-
ber of total lysines, suggesting site specificity of succinylation.
For instance, the trifunctional enzyme a subunit has 66 lysines,
of which 22 are succinylated (33%). In contrast, nicotinamide
nucleotide transhydrogenase, an enzyme involved in mitochon-
drial reactive oxygen species detoxification, has 61 lysines, of
which only three are succinylated (5%) (Table S2). This differ-
ence is not due to protein abundance, as their expression levels
in KO livers are not significantly altered fromWT livers (Table S3).
To date, no protein with lysine acetyl- or succinyl-transferase
activity has been identified within mitochondria. This raises a
question as to what mechanism is responsible for the wide-
spread but specific lysine acylation of mitochondrial proteins
that we and others have identified (Hebert et al., 2013; Kim
et al., 2006; Rardin et al., 2013). In the absence of evidence for
such a transferase, chemical modification due to the abundance
of acyl-CoAs (e.g., acetyl-CoA, succinyl-CoA) and the relative
high pH in mitochondria is a possibility (Wagner and Payne,
2013). If chemical, nonenzymatic reactions are producing these
modifications, protein biophysical parameters, such as a spe-
cific lysine’s pKa, solvent accessibility, and tertiary structure as
well as physiological parameters, such as microenvironmental
acyl-CoA levels and protein supercomplex compartmentaliza-
tion in mitochondria, would be expected to determine the spec-
ificity of these acylation reactions.
Our quantitative analysis by MS1 filtering measured the
relative precursor ion abundance of succinylated peptides. In
contrast to the Park et al. study, we employed a label-free quan-
titative approach to control for biological variability by comparing
lysine succinylation directly frommouse liver mitochondria using
five WT and five KO animals as opposed to a single biological
replicate using MEFs. This approach allowed us to demonstrate
statistically that over 90 sites were significantly increased in the
KO by more than 10-fold, as compared to only 28 observed in
MEFs from the Park et al. study. This difference is likely due to
the greater overall abundance of lysine succinylation in liver tis-
sue as compared to MEFs, as well as lysine succinylation being
more abundant in mitochondria as opposed to other cellular
compartments. In addition, our previous analysis of lysine acet-
ylation in liver mitochondria from WT and Sirt3/ mice, where
only 25 sites had greater than a 10-fold increase (Rardin et al.,
2013), indicates a greater relative response to the lack of
SIRT5 desuccinylase activity in the Sirt5/ mouse than the dif-
ference seen in theSirt3/mousemodel. However, it remains to
be determined if differences exist in the relative site occupancy
of succinylation versus acetylation, as methods for directly
determining precise stoichiometries have not been successfully
applied to lysine acyl modifications. Moreover, our 2-fold cutoff
does not preclude the possibility that lower fold changes may
have functional significance. All quantified peptides with statisti-
cal significance are provided as a resource for interrogation of in-
dividual sites and proteins (Table S2). Finally, caution should also
be taken in overinterpreting some of these very large changes
(>20-fold) as in many cases the WT signal was near the lower
limit of detection.
Our previous SIRT3 study has also allowed us to examine
the overlap between acetylation and succinylation at specificetabolism 18, 920–933, December 3, 2013 ª2013 Elsevier Inc. 931
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succinylation and acetylation is observed, with 24% of SIRT5
target sites also targeted by SIRT3. SIRT3 and SIRT5 target
proteins are enriched in overlapping pathways including fatty
acid b-oxidation, ketogenesis, and TCA cycle. Surprisingly,
Park et al.’s comparison in MEFs identified only 24% overlap
between the two acyl modifications, indicating that within mito-
chondria there is much greater likelihood for coregulation of
mitochondrial proteins than in other subcellular compartments.
Crosstalk between posttranslational modifications has been
widely observed across histones and signaling proteins such
as p53 (Latham and Dent, 2007; Olsson et al., 2007). The
differential regulation of proteins in common pathways by two
mitochondrial sirtuins with distinct enzymatic activities may sug-
gest a crosstalk or synergy between acetylation and succinyla-
tion in regulating mitochondrial metabolic networks. These
important questions will be the focus of future investigations
on the role of protein acylation in mitochondrial biology and
metabolic regulation.
EXPERIMENTAL PROCEDURES
Mass Spectrometry and Chromatographic Parameters
All samples used for MS1 filtering experiments were analyzed by reverse-
phase LC-ESI-MS/MS with an Eksigent Ultra Plus nano-LC 2D HPLC system
(Dublin, CA) connected to a quadrupole time-of-flight TripleTOF 5600 mass
spectrometer (AB SCIEX) in direct injection mode. See Supplemental Experi-
mental Procedures for technique details.
Bioinformatic Database Searches
MS data sets were analyzed and searched using Mascot server version 2.3.02
(Matrix Sciences, Boston, MA) and ProteinPilot (AB SCIEX 4.5 B) with the
Paragon algorithm (4.5, 1656). All data files were searched using the SwissProt
2013_01 database with a total of 538,849 sequences, but restricted to Mus
musculus (16,580 protein sequences). See Supplemental Experimental Proce-
dures for details.
Generation of Sequence Logos
To generate sequence logos, we first determined the 21 amino acid sequence
context for each modified peptide. We aligned the modified sequence to the
full protein sequence downloaded from UniProt (mouse proteome, accessed
May 10, 2013) and extracted the 21 amino acid interval from the UniProt
sequence. These context sequences were analyzed with IceLogo (Colaert
et al., 2009) by comparison to context sequences from an appropriate, nonre-
dundant set of control lysines. As one such control set, we extracted the
sequence context for all lysines on all proteins that appear in our data set
from the UniProt sequences. All IceLogo analyses were performed on nonre-
dundant sets (e.g., we subtracted SuK context sequences from the control set
of all lysines before logo generation).
Conservation Index of Lysine Succinylation Sites
Succinylated peptides that are nonredundant, with distinct peaks, were
mapped to orthologous proteins for conservation analysis (Table S5). We
downloaded the full sequence from UniProt and aligned it to the nr database
using blastpgp (BLAST suite 2.2.18) (Altschul et al., 1997). To ensure high-
quality multiple alignment, we required (1) sequence identity of 30%–94%
to the query mouse protein and (2) that > 10 such hits could be found. We
generated the multiple alignment with CLUSTALW (2.0.12) using default
settings (Larkin et al., 2007). We computed conservation indices for each
modified lysine by: (1) counting the number of conserved lysines across
the seven queried species and (2) using AL2CO on the alignment (Pei and
Grishin, 2001). When calculating rates of mutation to various amino acids,
we excluded sites that are absent from the multiple alignment in a given
species.932 Cell Metabolism 18, 920–933, December 3, 2013 ª2013 ElsevierPathway Analysis
Pathway analysis was performed with Reactome (Vastrik et al., 2007), which
uses all mouse proteins as the comparison set. For other overrepresentation
analyses, such as overrepresentation of SIRT5 target sites on particular pro-
teins, we calculated a binomial probability based on the overall distribution
of a feature in the data set (e.g., fraction of SuK sites that are SIRT5 targets
in the overall data set).
Sample Preparation for Mouse Liver Mitochondrial Protein Lysate
Livers were collected from five wild-type and five Sirt5/ male mice at
16weeks of age in the presence of deacetylase inhibitors (20mMnicotinamide
and 1 mM trichostatin A), and mitochondria were isolated by differential centri-
fugation as described previously (Hirschey et al., 2009). For additional details
see Supplemental Information.
Deuterium-Palmitate Oxidation Assay and Tritium-Palmitate
Oxidation Assay
See Supplemental Experimental Procedures for detailed information.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures, Supplemental Experimental
Procedures, and five tables and can be found with this article online at
http://dx.doi.org/10.1016/j.cmet.2013.11.013.
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